52.90
+0.90
+(1.73%)
At close: 1:30:38 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Pei Kan Ph.D. | President, GM & Director | -- | -- | -- |
| Ms. Winny Yang | VP of Finance & Accounting | -- | -- | -- |
| Mr. Hui-An Pao | Vice President of Operations | -- | -- | -- |
| Ms. Ru-Yun Lin M.B.A. | Vice President of Administration | -- | -- | 1966 |
Pharmosa Biopharm Inc.
No. 66, Sanchong Road
3rd Floor - 3 Nangang District
Taipei City, 11502
Taiwan
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It is developing L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei City, Taiwan.
Corporate Governance
Pharmosa Biopharm Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%
6657.TW Energenesis Biomedical CO.,LTD.
50.90
+1.39%
6662.TWO BioLASCO Taiwan Co., Ltd.
33.00
-0.30%
4168.TWO GlycoNex Incorporation
24.00
0.00%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
6885.TW BRIM Biotechnology, Inc.
28.90
-2.03%
4157.TWO TaiGen Biopharmaceuticals Holdings Limited
10.70
0.00%
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
6733.TWO BioGend Therapeutics Co., Ltd.
33.00
0.00%
6461.TWO Intech Biopharm Corporation
24.85
+0.20%